Preferred name | sodium salicylate |
Trivial Name | Sodium salicylate |
Short Description | 2-hydroxybenzoic acid, monosodium salt |
Formula | C7 H5 Na O3 |
CAS Number | 54-21-7 |
Deleted CAS Number | 18495-69-7 |
ECHA Number | 200-198-0 |
FDA UNII | WIQ1H85SYP |
Beilstein Number | 3732792 |
MDL | MFCD00002440 |
Bio Activity Summary | External link |
NMR Predictor | External link |
Synonyms |
|
Google Scholar | Start search |
Google Books | Start search |
Google Patents | Start search |
Perfumer & Flavorists | Start search |
EU Patents | Start search |
PubMeb | Start search |
NCBI | Start search |
sodium;2-hydroxybenzoate | |
NIST Chemistry WebBook: | Search Inchi |
Canada Domestic Sub. List: | 54-21-7 |
Pubchem (cid): | 16760658 |
Pubchem (sid): | 134971649 |
(IUPAC): | Atomic Weights of the Elements 2011 (pdf) |
Videos: | The Periodic Table of Videos |
tgsc: | Atomic Weights use for this web site |
(IUPAC): | Periodic Table of the Elements |
FDA Indirect Additives used in Food Contact Substances: | View |
CHEBI: | View |
CHEMBL: | View |
KEGG (GenomeNet): | C07587 |
HMDB (The Human Metabolome Database): | Search |
MedlinePlusSupp: | View |
ChemSpider: | View |
Wikipedia: | View |
American Elements | BOC Sciences |
LBB Specialties | EMD Millipore |
Glentham Life Sciences | Penta International |
Santa Cruz Biotechnology | Sigma-Aldrich: Sigma |
Penta International Corporation |
Material listed in food chemical codex | No |
Molecular weight | 160.1042175293 |
Vapor Pressure | 4.4E-5 mmHg @ 25 °C |
Flash Point TCC Value | 144.5 °C TCC |
logP (o/w) | 2.061 est |
Solubility | |
water, 1.25E+05 mg/L @ 25 °C (exp) | Yes |
water, 1e+006 mg/L @ 25 °C (est) | Yes |
Applications | |
Other purposes | Preservatives |
Cosmetic purposes | Denaturants , Preservatives |
Preferred SDS: View | |
Hazards identification | |
Classification of the substance or mixture | |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) | |
None found. | |
GHS Label elements, including precautionary statements | |
Pictogram | |
Hazard statement(s) | |
None found. | |
Precautionary statement(s) | |
None found. | |
Oral/Parenteral Toxicity: | |
intravenous-dog LD50 562 mg/kg BEHAVIORAL: ANALGESIA Archives Internationales de Pharmacodynamie et de Therapie. Vol. 149, Pg. 571, 1964. intraperitoneal-dog LDLo 990 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1392, 1935. oral-dog LDLo 450 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1392, 1935. intraperitoneal-guinea pig LDLo 900 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1392, 1935. oral-human LDLo 700 mg/kg LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: EXCITEMENT BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) New England Journal of Medicine. Vol. 232, Pg. 617, 1945. intramuscular-mouse LD50 760 mg/kg Acta Paediatrica Scandinavica. Vol. 59, Pg. 517, 1970. intraperitoneal-mouse LD50 500 mg/kg Strahlentherapie. Vol. 127, Pg. 245, 1965. intravenous-mouse LD50 500 mg/kg British Patent Document. Vol. #1009195 oral-mouse LD50 540 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 572, 1955. intravenous-rabbit LD50 415 mg/kg Kiso to Rinsho. Clinical Report. Vol. 13, Pg. 791, 1979. oral-rabbit LD50 1700 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 89, Pg. 205, 1947. intraperitoneal-rat LD50 542 mg/kg Kiso to Rinsho. Clinical Report. Vol. 13, Pg. 791, 1979. oral-rat LD50 930 mg/kg BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. Vol. 36(1-4), Pg. 10, 1989. | |
Dermal Toxicity: | |
subcutaneous-dog LDLo 200 mg/kg LUNGS, THORAX, OR RESPIRATION: DYSPNEA LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Revue Medicale de la Suisse Romande. Vol. 15, Pg. 561, 1895. subcutaneous-frog LDLo 250 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1392, 1935. subcutaneous-guinea pig LDLo 800 mg/kg LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: EXCITEMENT CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) Revue Medicale de la Suisse Romande. Vol. 15, Pg. 561, 1895. subcutaneous-mouse LD50 550 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 25, 1958. | |
Inhalation Toxicity: | |
Not determined |
Category: | |||
preservatives | |||
Recommendation for sodium salicylate usage levels up to: | |||
not for fragrance use. | |||
Recommendation for sodium salicylate flavor usage levels up to: | |||
not for flavor use. |
EPI System: View |
ClinicalTrials.gov:search |
Daily Med:search |
Chemical Carcinogenesis Research Information System:Search |
AIDS Citations:Search |
Cancer Citations:Search |
Toxicology Citations:Search |
EPA Substance Registry Services (TSCA):54-21-7 |
EPA ACToR:Toxicology Data |
EPA Substance Registry Services (SRS):Registry |
Laboratory Chemical Safety Summary :16760658 |
National Institute of Allergy and Infectious Diseases:Data |
WGK Germany:1 |
sodium;2-hydroxybenzoate |
Chemidplus:0000054217 |
RTECS:VO5075000 for cas# 54-21-7 |